A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery Disease Theocharis KoufakisEvangelos N. LiberopoulosKalliopi Kotsa Current Opinion 15 March 2022 Pages: 357 - 361
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future Filipe FerrariRafael S. ScheffelRicardo Stein Review Article 27 December 2021 Pages: 363 - 383
A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy Michael OsekowskiAdam TrytellElizabeth D. Paratz Review Article 14 February 2022 Pages: 385 - 393
Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies Kwang-Hee ShinHye Duck Choi Systematic Review 20 December 2021 Pages: 395 - 406
Comparison of Direct Oral Anticoagulants for Acute Hospital Mortality in Venous Thromboembolism Yuichiro OkushiKenya KusunoseMasataka Sata Original Research Article 20 December 2021 Pages: 407 - 416
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin-Induced Thrombocytopenia Kyle DavisJamie SebaalySarah A. Nisly Original Research Article 18 January 2022 Pages: 417 - 424
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy Mark J. AlbertsJinghua HeVeronica Ashton Original Research Article Open access 29 January 2022 Pages: 425 - 436
Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin for Treating Left Ventricular Thrombus John HeraldJesse GoitiaMing-Sum Lee Original Research Article 29 March 2022 Pages: 437 - 444
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy Mark H. RozenbaumDiana TranJose Nativi-Nicolau Original Research Article Open access 30 March 2022 Pages: 445 - 450
Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction Connie KangYvette N. Lamb Adis Drug Evaluation 28 May 2022 Pages: 451 - 459
Comment on: “A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy” Yvonne BonomoSean DaughertyAmanda Norman Letter to the Editor 21 June 2022 Pages: 461 - 462